Abstract
Prostaglandins (PGs) are produced from arachidonic acid by a cascade of enzymes, the initial step being the conversion of arachidonic acid to PGG2 by cyclooxygenase. In the next step, PGG2 is converted to PGH2, and it is at this stage that an oxidative radical is generated, presumably ·OH, which is capable of inactivating several enzymes of the arachidonic acid cascade1,2. This inactivation can be prevented by radical scavengers. MK 447, a phenolic compound with such properties, was indeed found to facilitate the conversion of PGG2 to PGH2 and therefore to enhance PGE2 synthesis2,3. MK447 also inhibits irritant-induced inflammation in mice and rats; this was thought to depend on radical scavenging, which led Kuehl and colleagues to suggest that PGG2 and ·OH are mediators of inflammation2,3. We have tested MK447 analogues containing asymmetric centres and report here that although both antipodes were equipotent radical scavengers and stimulators of prostaglandin synthesis, only the ( + ) antipodes had anti-inflammatory and diuretic4 properties. This indicates that the radical scavenging properties and pharmacological actions of MK 447 and derivatives are not interdependent and questions the pro-inflammatory role of PGG2.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kuehl, F. A. Jr & Egan, R. W. Science 210, 978–984 (1980).
Keuhl, F. A. Jr, Humes, J. L., Torchiana, M. L., Ham, E. A. & Egan, R. W. in Advances in Inflammation Research Vol. 1 (eds Weissmann, G., Samuelsson, B. & Paoletti, R.) 419–430 (Raven, New York, 1979).
Kuehl, F. A. Jr et al. Nature 265, 170–173 (1977).
Scriabine, A. et al. J. Pharmac. exp. Ther. 208, 148–154 (1979).
Ogino, N., Miyamoto, T., Yamamoto, S. & Hayaishi, O. J. biol. Chem. 252, 890–895 (1977).
Tocco, D. J. et al. Pharmacologist 20, 214 (1978).
Egan, R. W., Galen, P. H., Beveridge, G. C., Phillips, G. B. & Marnett, L. J. Prostaglandins 16, 861–869 (1978).
Mason, R. T. & Staszewska-Barczak, J. J. clin. exp. Pharmac. Physiol. 6, 678–685 (1979).
Takeguchi, C., Kohno, E. & Sih, C. J. Biochemistry 10, 2372–2376 (1971).
Winter, C. A., Risley, E. A. & Nuss, G. W. Proc. Soc. exp. Biol. Med. 111, 554–557 (1962).
Branceni, D., Azadian-Boulanger, G. & Jequier, R. Archs int. Pharmacodyn. 152, 15–24 (1964).
Kemper, F. & Ameln, G. Z. ges. exp. Med. 131, 407–415 (1959).
Flückiger, E., Schlach, W. & Taeschler, M. Schweiz. med. Wschr. 93, 1232–1237 (1963).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Payne, T., Dewald, B., Siegl, H. et al. Radical scavenging and stimulation of prostaglandin synthesis not anti-inflammatory?. Nature 296, 160–162 (1982). https://doi.org/10.1038/296160a0
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1038/296160a0
This article is cited by
-
Inhibition of interleukin-1 release by IX 207-887
Agents and Actions (1990)
-
Free radicals as a target of anti-rheumatic drug therapy
Agents and Actions (1984)


